V. Canva

The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids

Alexandre Louvet, Sylvie Naveau, Marcelle Abdelnour et al. · Hepatology · 2007 · 725 citations · Full text

Medicine, Pharmacology, Hepatic Pharmacotherapy +16

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

Christophe Hézode, Hélène Fontaine, Céline Dorival et al. · Journal of Hepatology · 2013 · 431 citations

Pharmacy, Internal Medicine, Pharmacotherapy +12

Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis

Christophe Hézode, Hélène Fontaine, Céline Dorival et al. · Gastroenterology · 2014 · 260 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Impaired expression of the peroxisome proliferator–activated receptor alpha during hepatitis C virus infection

Sébastien Dharancy, Mathilde Body–Malapel, Gabriel Perlemuter et al. · Gastroenterology · 2005 · 203 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +12

Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids

Alexandre Louvet, Emmanuel Diaz, Sébastien Dharancy et al. · Journal of Hepatology · 2007 · 163 citations

Medicine, Internal Medicine, Pharmacology +12